Overview

The Drug Implementation Research group’s mission is the development and implementation of therapies for poverty-related infectious diseases (PRID) including malaria, HIV/AIDS, filariasis, schistosomiasis and other infections. Our target populations are made of women of childbearing potential, infants, children and adolescents in sub-Saharan Africa. This mission is embedding in BNITM Strategy that is to combat poverty-related and neglected diseases through testing of new drugs directed against tropical diseases in controlled clinical trials and the development of innovative tools to combat diseases.